Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
Revised Drug Labels for Yaz and Yasmin The FDA recently issued a Drug Safety Communication informing the public it has completed a review study of the risk of blood clots in women taking birth control containing dropsirenone. Drospirenone is a synthetic form of the female hormone progesterone, and is also called progestin. The study concludes [...]
Yaz and Yasmin Birth Control Pill Settlement of 500 Cases Reported for $110 Million It was reported in Bloomberg on Friday that Bayer AG, the manufacturer of the blockbuster birth control drugs, Yaz and Yasmin has settled about 500 lawsuits arising out of blood clot injuries alleged to have been caused by the drugs. It [...]
Yaz Lawwuit The first Yaz of case set to go to trial on January 9th has taken an interesting turn. The federal judge overseeing thousands of Yaz, Yasmin and Ocella venous thromboembolism lawsuits has ordered that all parties instead meet with a special mediator in order to negotiate a settlement for the litigation. The December [...]
On December 8th, an FDA advisory panel will meet in order to further discuss the safety of drospirenone-containting birth control pills like Yaz and Yasmin. These newer-generation oral contraceptives have been the subject of heated debate amongst health regulators worldwide. In the U.S., federal regulators are asking for more information, pushing for more research on [...]
In an online news article posted to Bloomberg’s website this week, it seems that pharmaceutical giant, Bayer AG, could have misled women regarding the potential health risks associated with use of their newer generation of birth control pills. According to information collected from the review of internal company e-mails, Bayer may have even sought to [...]
The fate of Bayer’s highly-controversial birth control pill, Yaz, is in the hands of the U.S. Food and Drug Administration. The regulatory agency will meet on December 8th in order to determine whether or not the drug should be allowed to stay on the market. Following the analysis of data collected from an agency-funded study [...]
According to a study published on October 25 in The British Medical Journal, newer-generation birth control pills, specifically those containing the progestogen hormones drospirenone, desogestrel or gestodene, double the risk for venous thromboembolism (VTE), compared to older-generation contraceptives containing the progestogen hormone, levonorgestrel. Best-selling brands and generics like Yaz and Ocella are examples of the [...]
Amid a flurry of Yaz lawsuits, Bayer Healthcare, eager to hold its top spot in the oral contraceptive market, launched a new birth control pill last year… Natazia. Bayer cleverly launched Yaz in 2006, promising that the new formulation birth control pill – a combination of ethinyl estradiol and drospirenone – not only prevented pregnancy [...]
